ACACA and metabolic dysfunction-associated steatotic liver disease: Treatments such as metformin, which also helps to regulate type II diabetes, along with GS-0976 and MK-4074, potent inhibitors of ACC-1 and ACC-2, have advanced the understanding of the crucial role that these enzymes play in regulating NAFLD (non-alcoholic fatty liver disease) [12,13,14].